Prenetics Global PRE
NASDAQ PRE
$24.19 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Prenetics Global (PRE) Non-Current Deffered Revenue (2023)

Prenetics Global's (PRE) quarterly Non-Current Deffered Revenue came in at $3.5 million in Q4 2023.

Analysis

Prenetics Global (PRE) Non-Current Deffered Revenue (2023) Analysis & Trends

Prenetics Global (PRE) has reported Non-Current Deffered Revenue for 1 consecutive years, with $3.5 million the latest figure, recorded in Q4 2023.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $3.5 million in Q4 2023; TTM through Dec 2023 was $3.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at $3.5 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue was $3.5 million for Q4 2023 at Prenetics Global.
  • Over five years, Non-Current Deffered Revenue peaked at $3.5 million in Q4 2023 and troughed at $3.5 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn -
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn -
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn -
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn -
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn 10.19 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn -
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn -
8 Anbio Biotechnology 755.43 Mn 743.53 Mn - -
9 QuidelOrtho 725.35 Mn 601.95 Mn - -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.53 Mn